Pulse Biosciences

General Information

We are a development stage medical device company using a novel and proprietary platform technology called Nano-Pulse Electro-Signaling or NPES. NPES is a local and drug-free technology that utilizes nanosecond pulsed electric fields to induce cell signaling and the activation of cellular pathways in tissue. We believe that NPES can induce a variety of cellular responses including secretion, apoptosis and necrosis by modulating the NPES pulses, making it applicable to a wide variety of cell types and therapeutic applications.

Employees: 12
Founded: 2014
Contact Information
Address 849 Mitten Road, Suite 104, Burlingame, CA 94010, US
Phone Number (650) 697-3939
Web Address http://www.pulsebiosciences.com
View Prospectus: Pulse Biosciences
Financial Information
Market Cap $50.3mil
Revenues $0.0 mil (last 12 months)
Net Income $-2.8 mil (last 12 months)
IPO Profile
Symbol PLSE
Exchange NASDAQ
Shares (millions): 5.0
Price range $4.00 - $4.00
Est. $ Volume $20.0 mil
Manager / Joint Managers MDB Capital Group/ Feltl and Company
CO-Managers -
Expected To Trade: 5/18/2016
Status: Priced
Quiet Period Expiration Date:
Lock-Up Period Expiration Date:
SCOOP Rating
Rating Change